PPR-169 - Occurrence of polypharmacy and its relationship with comorbidities: A descriptive cross-sectional study from a secondary care clinic setting in Sri Lanka

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPR-169
• By: DILMI DIAS WICKRAMASINGHE, Nadeesha
• Co-author(s): Ms Mudiyanselage Anuththara Upamali Abeykoon (Department of Pharmacy, Faculty of Health Sciences, The Open University Of Sri Lanka, Nugegoda, Colombo, Sri Lanka)
  Mr Wijesuriya Arachilage Rohan Ruwan Sirilal (Department of Pharmacy, Faculty of Health Sciences, The Open University Of Sri Lanka, Nugegoda, Colombo, Sri Lanka)
  Ms Liyana Lekamalage Kaumudie Satheeka Jayasiri (Department of Pharmacy, Faculty of Health Sciences, The Open University Of Sri Lanka, Nugegoda, Colombo, Sri Lanka)
  Ms Semasinghe Bandaralage Himali Priyadarshani Kumari (Department of Pharmacy, Faculty of Health Sciences, The Open University Of Sri Lanka, Nugegoda, Colombo, Sri Lanka)
  Ms Nadeesha Dilmi Dias Wickramasinghe (Department of Pharmacy, Faculty of Health Sciences, The Open University Of Sri Lanka, Nugegoda, Colombo, Sri Lanka)
  
• Abstract:

  Introduction:
  Polypharmacy is defined as the concurrent use of five or more medications by an individual patient. Polypharmacy is associated with increased adverse drug events, increased health expenditures, and issues in medication adherence. Sri Lanka is a Low Middle-Income Country (LMIC) providing free healthcare to all citizens and thus..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login